Both stand alone prescription drug
plans (PDPs) and Medicare Advantage Prescription Drug (MA-PDs)
plans will be required to submit drug pricing and pharmacy network
data to CMS. These data will be made publicly available to people
with Medicare through the new Medicare prescription drug plan
finder tool that will be launched in the fall of 2005 on
www.medicare.gov. The purpose of the data is to enable people with
Medicare to compare, learn, select and enroll in a plan that best
meets their needs.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.